Similar Items: Development of human monoclonal antibodies against TARM1 by yeast display
- Net Present Value Impact of FDA’s Phase 3 Waivers on Monoclonal Antibody Biosimilar Development
- Identifying transcription factors controlling the basal expression of human MRP4 highlights a substantial role for Sp1
- Development of novel monoclonal antibodies for detection of pan-Lassa virus
- Repurposing dihydroartemisinin as a novel anticancer agent against colorectal cancer stem cells
- Mining Bioactive Compounds against Drug-Resistant Microorganisms from Ethnomedicine: Examples of 32 Ethnic Medicines in Yunnan
- The cooperative regulation of miR‐221 by APE1 and AUF1 impacts p27Kip1 defining a miR signature relevant for cervical cancer